Academy of Consultation-Liaison Psychiatry

Check Out What the SIGs are Doing

… And how to join another group that interests you

Want to join an Academy SIG? For instructions, visit https://www.clpsychiatry.org/sigs/how-to-join/

Addiction & Toxicology
Bioethics
Community Consultation-Liaison Psychiatry Practice
HIV/AIDS Psychiatry
Neuropsychiatry
Pediatric C-L Psychiatry
Psychological Considerations

Addiction & Toxicology Co-chairs: David Hathaway, MD, & Thida Thant, MD
The Addiction & Toxicology SIG continues to thrive, now with more than 750 members and an expanded leadership team including Jordan Paluch, DO (Trainee Liaison), Brent Schnipke, MD (Education), and Samantha Zwiebel, MD (Scholarship & Conference Submissions). Our virtual meetings remain well attended, and the listserv continues to be a lively forum for sharing clinical pearls, emerging evidence, and opportunities for collaboration. At CLP 2024, held in Miami, Florida, SIG members had a significant presence across sessions and posters. Highlights included a general session on integrating addiction care into C-L Psychiatry (Drs. Katy Lunny, Joji Suzuki, Simon Sidelnik, and Scott Winder) and an oral paper by Dr. Sidelnik on rethinking methadone and QTc risk in the fentanyl era. In the Neuropsychiatry track, Jon Sole, MD, MSc, presented on Korsakoff syndrome: manifestations and management strategies, and Matthew Gunther, MD, MA, presented a case series on dextroamphetamine for aggression in Korsakoff syndrome—both coauthored by José Maldonado, MD, FACLP, FACFE. Poster presentations spanned a wide range of addiction and toxicology topics, including xylazine, cannabis hyperemesis syndrome, Delta-8 THC–induced psychosis, nitrous oxide use disorder, gabapentin-associated parasomnias, and an umbrella review of phenobarbital vs. benzodiazepines for alcohol withdrawal. Dr. Jeong Hoo Lee, with Dr. Suzuki, presented on the use of phosphatidylethanol testing in inpatient alcohol withdrawal management, winning the First Prize Poster Award, and Dr. Suzuki was also inducted as a new FACLP. Our SIG-sponsored webinar, Management of Acute Benzodiazepine Withdrawal—presented by Anjali Chandra, MD, with discussant Avram Mack, MD, and moderated by David Fipps, DO—broke the record for most registrants in the ACLP case conference series; Dr. Fipps was subsequently honored with the Alan Stoudemire Award for innovation and excellence in C-L Psychiatry education. Ongoing SIG meetings have tackled practical issues such as emerging contaminants (xylazine, kratom, medetomidine), inpatient naltrexone access, psilocybin-induced mania, addiction consult service models (cf., PMID: 38657952), alcohol-related test interpretation and turnaround (PMID: 39362720; 39956128), and the emergence of GLP-1 receptor agonists as potential treatments for substance use disorders, as well as their general safety and tolerability (PMIDs: 39092831, 38958939), and the evolving landscape of cannabis use and mental health care (news.cuanschutz.edu). Looking ahead, the SIG plans to continue to refine officer roles, develop trainee educational resources, and foster scholarship and collaboration to advance addiction care in C-L Psychiatry. We welcome new members and collaborators to join us in advancing this mission. Visit the Addiction & Toxicology SIG page on the Academy website here.

Addiction & Toxicology
Co-chairs: David Hathaway, MD, & Thida Thant, MD

The Addiction & Toxicology SIG continues to thrive, now with more than 750 members and an expanded leadership team including Jordan Paluch, DO (Trainee Liaison), Brent Schnipke, MD (Education), and Samantha Zwiebel, MD (Scholarship & Conference Submissions). Our virtual meetings remain well attended, and the listserv continues to be a lively forum for sharing clinical pearls, emerging evidence, and opportunities for collaboration.

At CLP 2024, held in Miami, Florida, SIG members had a significant presence across sessions and posters. Highlights included a general session on integrating addiction care into C-L Psychiatry (Drs. Katy Lunny, Joji Suzuki, Simon Sidelnik, and Scott Winder) and an oral paper by Dr. Sidelnik on rethinking methadone and QTc risk in the fentanyl era. In the Neuropsychiatry track, Jon Sole, MD, MSc, presented on Korsakoff syndrome: manifestations and management strategies, and Matthew Gunther, MD, MA, presented a case series on dextroamphetamine for aggression in Korsakoff syndrome—both coauthored by José Maldonado, MD, FACLP, FACFE. Poster presentations spanned a wide range of addiction and toxicology topics, including xylazine, cannabis hyperemesis syndrome, Delta-8 THC–induced psychosis, nitrous oxide use disorder, gabapentin-associated parasomnias, and an umbrella review of phenobarbital vs. benzodiazepines for alcohol withdrawal. Dr. Jeong Hoo Lee, with Dr. Suzuki, presented on the use of phosphatidylethanol testing in inpatient alcohol withdrawal management, winning the First Prize Poster Award, and Dr. Suzuki was also inducted as a new FACLP.

Our SIG-sponsored webinar, Management of Acute Benzodiazepine Withdrawal—presented by Anjali Chandra, MD, with discussant Avram Mack, MD, and moderated by David Fipps, DO—broke the record for most registrants in the ACLP case conference series; Dr. Fipps was subsequently honored with the Alan Stoudemire Award for innovation and excellence in C-L Psychiatry education.

Ongoing SIG meetings have tackled practical issues such as emerging contaminants (xylazine, kratom, medetomidine), inpatient naltrexone access, psilocybin-induced mania, addiction consult service models (cf., PMID: 38657952), alcohol-related test interpretation and turnaround (PMID: 39362720; 39956128), and the emergence of GLP-1 receptor agonists as potential treatments for substance use disorders, as well as their general safety and tolerability (PMIDs: 39092831, 38958939), and the evolving landscape of cannabis use and mental health care (news.cuanschutz.edu).

Looking ahead, the SIG plans to continue to refine officer roles, develop trainee educational resources, and foster scholarship and collaboration to advance addiction care in C-L Psychiatry. We welcome new members and collaborators to join us in advancing this mission.

Visit the Addiction & Toxicology SIG page on the Academy website here.

BIOETHICS Chair: Samantha Zwiebel, MD
Emergency psychiatric talks at the 2024 Annual Meeting included: Clinical Updates in Emergency Psychiatry: Integrated Care at its Best (sponsored by our SIG, the American Association for Emergency Psychiatry, and the Behavioral Emergency Section of ACEP). Brief oral papers: The membership of the Bioethics SIG has been busy with several projects and abstract submissions. Five abstracts were accepted for workshops for the Annual Meeting this November. The Bioethics SIG Education Workgroup has been busy updating the bioethics bibliography that lives on the SIG’s main page, still a work in progress but getting close to the finish line. CLP Fellowship program directors were surveyed regarding bioethics education as this subject is now an ACGME requirement, which has given us some direction on future projects to create content aimed at helping fellowships meet this requirement. Finally, members of the SIG have created a How To guide on treatment over objection to complement the new guide on capacity evaluations—both soon to be published on the ACLP website! Visit the Bioethics SIG page on the Academy website here.

BIOETHICS
Chair: Samantha Zwiebel, MD

Emergency psychiatric talks at the 2024 Annual Meeting included:

Clinical Updates in Emergency Psychiatry: Integrated Care at its Best (sponsored by our SIG, the American Association for Emergency Psychiatry, and the Behavioral Emergency Section of ACEP).
Brief oral papers:
The membership of the Bioethics SIG has been busy with several projects and abstract submissions. Five abstracts were accepted for workshops for the Annual Meeting this November. The Bioethics SIG Education Workgroup has been busy updating the bioethics bibliography that lives on the SIG’s main page, still a work in progress but getting close to the finish line. CLP Fellowship program directors were surveyed regarding bioethics education as this subject is now an ACGME requirement, which has given us some direction on future projects to create content aimed at helping fellowships meet this requirement. Finally, members of the SIG have created a How To guide on treatment over objection to complement the new guide on capacity evaluations—both soon to be published on the ACLP website!

Visit the Bioethics SIG page on the Academy website here.

COMMUNITY CONSULTATION-LIAISON PSYCHIATRY PRACTICE Chair: Hindi Mermelstein, MD, FACLP
The past few months have been one of change for the SIG. Dr Travis Fisher has graciously agreed to assume chairmanship with the formal transition to take place at the ACLP Annual Meeting in November 2025 in San Antonio. In preparation for this change we have reviewed the SIG mission, how it currently serves its members and the ACLP membership, as well as potential areas of growth. Times of transition are exciting as they present an opportunity for modification and change. It is a chance to become more involved, to suggest ways which may improve our service to our members and how to create stronger connections with other groups as well as better outreach to potential members. On behalf of Dr Travis, we invite all of you to join us at the Annual Meeting, to brainstorm with us and to help make this SIG what you want and need. Thank you for allowing me Hindi Mermelstein, MD, FACLP, to serve as the chairperson for all these years. It has been an honor to help shepherd this SIG forward and I look forward to continuing my involvement in a consulting role. See you all in November. If you want to contact either Dr Fisher or myself, please feel free to do so.

COMMUNITY CONSULTATION-LIAISON PSYCHIATRY PRACTICE
Chair: Hindi Mermelstein, MD, FACLP

The past few months have been one of change for the SIG. Dr Travis Fisher has graciously agreed to assume chairmanship with the formal transition to take place at the ACLP Annual Meeting in November 2025 in San Antonio. In preparation for this change we have reviewed the SIG mission, how it currently serves its members and the ACLP membership, as well as potential areas of growth.

Times of transition are exciting as they present an opportunity for modification and change. It is a chance to become more involved, to suggest ways which may improve our service to our members and how to create stronger connections with other groups as well as better outreach to potential members. On behalf of Dr Travis, we invite all of you to join us at the Annual Meeting, to brainstorm with us and to help make this SIG what you want and need.

Thank you for allowing me Hindi Mermelstein, MD, FACLP, to serve as the chairperson for all these years. It has been an honor to help shepherd this SIG forward and I look forward to continuing my involvement in a consulting role.

See you all in November. If you want to contact either Dr Fisher or myself, please feel free to do so.

HIV/AIDS PSYCHIATRY Co-chairs: Luis Pereira, MD & and Paulo Sales, MD
The HIV/AIDS Psychiatry SIG continues to grow and thrive, with over 700 members worldwide. We remain committed to advancing psychiatric care for people living with HIV (PWH) through scholarship, mentorship, and international collaboration across the globe. Our greatest achievement this year is the forthcoming publication of the Clinical Manual of HIV Psychiatry with the American Psychiatric Association Publishing. Edited by Drs. Luis Pereira, Paulo Sales, John Grimaldi, James Bourgeois, and Mary Ann Cohen, with contributions from many of our members, this comprehensive manual will serve as an essential clinical reference. Its release later this year marks a milestone for our field and a testament to our group’s collective scholarship, as we prepare for the publication of the Cohen’s Comprehensive Textbook of HIV Psychiatry, with Springer, led by Drs. Mary Ann Cohen, César Alfonso, and others, to be published in 2027. At the 2025 ACLP Annual Meeting, our SIG will host the interactive workshop Be PrEP-ared: Implementing Smart HIV/AIDS Prevention Using AI and Time-Tested Strategies. This session, featuring a multidisciplinary and career-diverse panel, will integrate evidence-based HIV prevention approaches (PrEP, PEP, lifestyle interventions) with novel digital applications such as clinical decision support systems. Our workgroups remain highly active: Substance Use Disorders (John Wells, Luis Pereira): advancing work on chemsex and methamphetamine use. Psychotherapy (Guida da Ponte): leading efforts on diagnosis and treatment of HIV-associated neurocognitive disorders (HAND). Telepsychiatry (Gabrielle Marzani): enhancing hybrid and remote psychiatric care. International collaborations: with symposia presented at the World Psychiatric Association (Mexico City 2024) and future submissions on transcultural perspectives in HIV psychiatry and medical education. Ongoing and upcoming manuscript initiatives include projects on antiretroviral neurotoxicity, the diagnosis and treatment of HAND in distressed systems (led by Drs. Guida da Ponte and Paulo Sales), as we prepare important steps towards the production of consensus statements next year and update our SIG’s website. As always, we welcome new members across all career stages and disciplines. If you are interested in contributing to guidelines, manuscripts, podcasts, or international collaborations, we encourage you to get involved. Together, our SIG continues to advance the science and practice of HIV psychiatry, building our community over compassionate care and innovation, as we celebrate our achievements and prepare for the opportunities to integrate Artificial Intelligence in our clinical lives. Visit the HIV/AIDS SIG page on the Academy website here.

HIV/AIDS PSYCHIATRY
Co-chairs: Luis Pereira, MD & and Paulo Sales, MD

The HIV/AIDS Psychiatry SIG continues to grow and thrive, with over 700 members worldwide. We remain committed to advancing psychiatric care for people living with HIV (PWH) through scholarship, mentorship, and international collaboration across the globe.

Our greatest achievement this year is the forthcoming publication of the Clinical Manual of HIV Psychiatry with the American Psychiatric Association Publishing. Edited by Drs. Luis Pereira, Paulo Sales, John Grimaldi, James Bourgeois, and Mary Ann Cohen, with contributions from many of our members, this comprehensive manual will serve as an essential clinical reference. Its release later this year marks a milestone for our field and a testament to our group’s collective scholarship, as we prepare for the publication of the Cohen’s Comprehensive Textbook of HIV Psychiatry, with Springer, led by Drs. Mary Ann Cohen, César Alfonso, and others, to be published in 2027.

At the 2025 ACLP Annual Meeting, our SIG will host the interactive workshop Be PrEP-ared: Implementing Smart HIV/AIDS Prevention Using AI and Time-Tested Strategies. This session, featuring a multidisciplinary and career-diverse panel, will integrate evidence-based HIV prevention approaches (PrEP, PEP, lifestyle interventions) with novel digital applications such as clinical decision support systems.

Our workgroups remain highly active:

Substance Use Disorders (John Wells, Luis Pereira): advancing work on chemsex and methamphetamine use.
Psychotherapy (Guida da Ponte): leading efforts on diagnosis and treatment of HIV-associated neurocognitive disorders (HAND).
Telepsychiatry (Gabrielle Marzani): enhancing hybrid and remote psychiatric care.
International collaborations: with symposia presented at the World Psychiatric Association (Mexico City 2024) and future submissions on transcultural perspectives in HIV psychiatry and medical education.

Ongoing and upcoming manuscript initiatives include projects on antiretroviral neurotoxicity, the diagnosis and treatment of HAND in distressed systems (led by Drs. Guida da Ponte and Paulo Sales), as we prepare important steps towards the production of consensus statements next year and update our SIG’s website.

As always, we welcome new members across all career stages and disciplines. If you are interested in contributing to guidelines, manuscripts, podcasts, or international collaborations, we encourage you to get involved. Together, our SIG continues to advance the science and practice of HIV psychiatry, building our community over compassionate care and innovation, as we celebrate our achievements and prepare for the opportunities to integrate Artificial Intelligence in our clinical lives.

Visit the HIV/AIDS SIG page on the Academy website here.

NEUROPSYCHIATRY Co-chairs: Durga Roy, MD, FACLP; Inder Kalra, MD
The Neuropsychiatry SIG consists of more than 900 members and is organized in the form of three major categories with task force leads for education, scholarship and SIG symposia. Members met at the Annual Meeting in Miami in 2024 and subdivided into subgroups based on area of interest. The subgroup leads have been active in connecting after the meeting to review projects and submissions for the Annual Meeting in 2025. The SIG continues to meet every two months via Zoom and continues to work on the development and expansion of three task forces, reflective of the SIG’s mission with discussion of a new task force dedicated to working on guidelines development. We have growing participation and many new members including trainees and students. Our task groups are busily working away on designated projects and being diligent about maintaining deadlines for scholarly products: SIG-sponsored symposia task force: Currently under the leadership of Dr. Badr Ratnakaran, the task force has expanded its participants with several abstracts accepted for presentation at the 2025 Annual Meeting, in areas of innovation in evaluation and management of catatonia, the neuropsychiatric impact of climate change, and ethics in neuropsychiatry. This task force also continues to meet independently outside of the regularly scheduled SIG meetings. The SIG’s focus remains on developing collaboration based on clinical content areas, enhancing member engagement, and continuing to provide leadership and assistance to trainees in developing their area of expertise. Education task force: Dr. Vincent Fryer has taken the lead on this task force, and group members continue to compile a list of online resources in neuropsychiatry. In collaboration with the Online Education Group. By this year’s Annual Meeting, the SIG will have a newly launched website of video lectures, literature references, and neuropsychiatry-focused websites among other educational resources for Academy member to access. The SIG has been invited to give an ACLP Education Committee-sponsored case conference and topics will include functional neurological disorders, traumatic brain injury, and autoimmune encephalitis. The online Neuropsychiatry education website is underway, and the task group will be sending a link to the SIG to enumerate top neuropsychiatric education resources to be built into our website. Robust monthly member case discussions via the listserv continue amongst our very active members. Scholarship task force: Under the leadership of Dr. Flannery Meredith, this task force has successfully led manuscript production. Several scholarship projects were published in 2025 including: the clinical challenges posed by catatonia in diagnosis of neurological and neurodevelopmental disorders accepted for publication in the Journal of Neuropsychiatry and Clinical Neurosciences; and an active ongoing collaboration with the Critical Care SIG for a chapter on TBI in the textbook of critical care psychiatry. The SIG is focused on engaging members in training for scholarship initiatives and the TBI Scholarship initiative is a resident-led initiative working on writing a scoping review of the Predictors of Outcomes One Year after TBI. The group has 10 ongoing projects currently in neuropsychiatric subspeciality groups such as functional neurological disorders, movement disorders, catatonia, and TBI. Inter-organization collaboration: This is the first year the SIG has been approached by the American Neuropsychiatric Association (ANPA) leadership for cross-collaboration around educational efforts. The first of this was an invited journal club presentation given by Durga Roy on her recent publication on headaches and mild TBI in the Journal of Neuropsychiatry and Clinical Neurosciences. The second was the ANPA grand rounds talk on Cognitive, Anxiety, and Depressive Disorders in the Fragile X-associated Tremor/Ataxia Syndrome, which was well-attended by the ACLP SIG members and ANPA members. The SIG is working on creating future collaborations with ANPA. Monthly member case reports: Case discussions continue amongst the listserv where members present a challenging, de-identified case on a neuropsychiatric syndrome for discussion amongst SIG members. This occurs on average once per quarter. Social media: The group has moved forward with developing a Twitter hashtag (Neuropsychiatry #CLPNEUROPSYCH) so that resources on C-L neuropsychiatry can be widely accessed. In the year ahead the Neuropsychiatry SIG will: Engage more medical students, residents, fellows and junior faculty by enhancing member engagement and creating opportunities for leadership within the SIG. Create a structure for supervision of trainees and early career members interested in neuropsychiatry. Continue to build opportunities for collaboration through ANPA, to provide our expertise as C-L psychiatrists who integrate neuropsychiatry into our work, and for ANPA to provide educational resources to us surrounding recent research advances in the field of neuropsychiatry. Continue to collaborate with newer SIGs such as the Critical Care SIG to create high quality content in the form of presentations for the Annual Meeting as well as continued scholarship and publications (currently we are contributing a chapter to the new Critical Care Psychiatry Textbook). Visit the Neuropsychiatry SIG page on the Academy website here.

NEUROPSYCHIATRY
Co-chairs: Durga Roy, MD, FACLP; Inder Kalra, MD

The Neuropsychiatry SIG consists of more than 900 members and is organized in the form of three major categories with task force leads for education, scholarship and SIG symposia.

Members met at the Annual Meeting in Miami in 2024 and subdivided into subgroups based on area of interest. The subgroup leads have been active in connecting after the meeting to review projects and submissions for the Annual Meeting in 2025.

The SIG continues to meet every two months via Zoom and continues to work on the development and expansion of three task forces, reflective of the SIG’s mission with discussion of a new task force dedicated to working on guidelines development. We have growing participation and many new members including trainees and students.

Our task groups are busily working away on designated projects and being diligent about maintaining deadlines for scholarly products:

SIG-sponsored symposia task force: Currently under the leadership of Dr. Badr Ratnakaran, the task force has expanded its participants with several abstracts accepted for presentation at the 2025 Annual Meeting, in areas of innovation in evaluation and management of catatonia, the neuropsychiatric impact of climate change, and ethics in neuropsychiatry.

This task force also continues to meet independently outside of the regularly scheduled SIG meetings. The SIG’s focus remains on developing collaboration based on clinical content areas, enhancing member engagement, and continuing to provide leadership and assistance to trainees in developing their area of expertise.

Education task force: Dr. Vincent Fryer has taken the lead on this task force, and group members continue to compile a list of online resources in neuropsychiatry. In collaboration with the Online Education Group. By this year’s Annual Meeting, the SIG will have a newly launched website of video lectures, literature references, and neuropsychiatry-focused websites among other educational resources for Academy member to access. The SIG has been invited to give an ACLP Education Committee-sponsored case conference and topics will include functional neurological disorders, traumatic brain injury, and autoimmune encephalitis.

The online Neuropsychiatry education website is underway, and the task group will be sending a link to the SIG to enumerate top neuropsychiatric education resources to be built into our website. Robust monthly member case discussions via the listserv continue amongst our very active members.

Scholarship task force: Under the leadership of Dr. Flannery Meredith, this task force has successfully led manuscript production. Several scholarship projects were published in 2025 including: the clinical challenges posed by catatonia in diagnosis of neurological and neurodevelopmental disorders accepted for publication in the Journal of Neuropsychiatry and Clinical Neurosciences; and an active ongoing collaboration with the Critical Care SIG for a chapter on TBI in the textbook of critical care psychiatry.

The SIG is focused on engaging members in training for scholarship initiatives and the TBI Scholarship initiative is a resident-led initiative working on writing a scoping review of the Predictors of Outcomes One Year after TBI.

The group has 10 ongoing projects currently in neuropsychiatric subspeciality groups such as functional neurological disorders, movement disorders, catatonia, and TBI.

Inter-organization collaboration: This is the first year the SIG has been approached by the American Neuropsychiatric Association (ANPA) leadership for cross-collaboration around educational efforts. The first of this was an invited journal club presentation given by Durga Roy on her recent publication on headaches and mild TBI in the Journal of Neuropsychiatry and Clinical Neurosciences. The second was the ANPA grand rounds talk on Cognitive, Anxiety, and Depressive Disorders in the Fragile X-associated Tremor/Ataxia Syndrome, which was well-attended by the ACLP SIG members and ANPA members. The SIG is working on creating future collaborations with ANPA.

Monthly member case reports: Case discussions continue amongst the listserv where members present a challenging, de-identified case on a neuropsychiatric syndrome for discussion amongst SIG members. This occurs on average once per quarter.

Social media: The group has moved forward with developing a Twitter hashtag (Neuropsychiatry #CLPNEUROPSYCH) so that resources on C-L neuropsychiatry can be widely accessed.

In the year ahead the Neuropsychiatry SIG will:

Engage more medical students, residents, fellows and junior faculty by enhancing member engagement and creating opportunities for leadership within the SIG.
Create a structure for supervision of trainees and early career members interested in neuropsychiatry.
Continue to build opportunities for collaboration through ANPA, to provide our expertise as C-L psychiatrists who integrate neuropsychiatry into our work, and for ANPA to provide educational resources to us surrounding recent research advances in the field of neuropsychiatry.
Continue to collaborate with newer SIGs such as the Critical Care SIG to create high quality content in the form of presentations for the Annual Meeting as well as continued scholarship and publications (currently we are contributing a chapter to the new Critical Care Psychiatry Textbook).

Visit the Neuropsychiatry SIG page on the Academy website here.

PEDIATRIC C-L PSYCHIATRY Co-chairs: Laura Markley, MD, FACLP; Julienne Jacobson, MD, FACLP
This past spring, the Pediatric C-L Psychiatry SIG collaborated on the development of several submissions for CLP 2025, including co-sponsored proposals with other SIGs. We are thrilled that many of these submissions have been accepted, with topics covering hospital-based violence, substance use, implementation of clinical care pathways, management of autism in the medical setting, and catatonia. Several oral papers and posters were also accepted, reflecting the breadth and strength of our members’ contributions. This fall marks an exciting leadership transition. After serving as co-chair since 2016, Dr. Laura Markley is stepping down from her role. We are delighted to welcome Dr. Haniya Raza as our new co-chair. Dr. Raza is a child, adolescent, and adult psychiatrist who serves as a medical officer with the Psychiatry Consultation-Liaison Service in the Office of the Clinical Director at the National Institute of Mental Health Intramural Research Program at the NIH. She has been an active and engaged member of the SIG for many years, and we are grateful for her willingness to step into this leadership position. Dr. Julienne Jacobson will remain in co-chairperson role throughout the year (during this transition), with plans to hand off the role to another active ACLP SIG member during the 2026 calendar year. Our SIG also continues to strengthen its partnership with AACAP’s Physically Ill Child Committee (PICC). Dr. Markley is currently serving a two-year appointed term on the PICC and will continue as liaison. Many of our members hold dual memberships in AACAP and ACLP, and AACAP has generously permitted all SIG members to participate in its professional listserv for several years. With more intentional collaboration, we hope to maximize shared expertise and amplify ACLP’s voice on important issues such as supporting youth boarding in emergency departments or medical units while awaiting psychiatric placement and advancing the management of catatonia in varied clinical settings, particularly given current challenges with access to ECT and the shortage of IV lorazepam. Looking ahead, we are working to recruit a subcommittee to refresh our SIG webpage and encourage continued use of the Pediatric SIG listserv as a hub for mentorship, clinical dialogue, and cross-institutional collaboration. We are especially excited that our SIG will be featured in the ACLP Case Conference Webinar series this year, with the opportunity to present a pediatric C-L Psychiatry case to colleagues across the field. In addition, we are proud to support Dr. Maryland Pao’s proposal to establish a dedicated Child and Adolescent Psychiatry Award within ACLP, and we will continue to advocate for this important recognition. We look forward to highlighting the work of our members through these initiatives and to continuing to grow the visibility, impact, and voice of pediatric C-L psychiatry within ACLP. Visit the Pediatric C-L Psychiatry SIG page on the Academy website here.

PEDIATRIC C-L PSYCHIATRY
Co-chairs: Laura Markley, MD, FACLP; Julienne Jacobson, MD, FACLP

This past spring, the Pediatric C-L Psychiatry SIG collaborated on the development of several submissions for CLP 2025, including co-sponsored proposals with other SIGs. We are thrilled that many of these submissions have been accepted, with topics covering hospital-based violence, substance use, implementation of clinical care pathways, management of autism in the medical setting, and catatonia. Several oral papers and posters were also accepted, reflecting the breadth and strength of our members’ contributions.

This fall marks an exciting leadership transition. After serving as co-chair since 2016, Dr. Laura Markley is stepping down from her role. We are delighted to welcome Dr. Haniya Raza as our new co-chair. Dr. Raza is a child, adolescent, and adult psychiatrist who serves as a medical officer with the Psychiatry Consultation-Liaison Service in the Office of the Clinical Director at the National Institute of Mental Health Intramural Research Program at the NIH. She has been an active and engaged member of the SIG for many years, and we are grateful for her willingness to step into this leadership position. Dr. Julienne Jacobson will remain in co-chairperson role throughout the year (during this transition), with plans to hand off the role to another active ACLP SIG member during the 2026 calendar year.

Our SIG also continues to strengthen its partnership with AACAP’s Physically Ill Child Committee (PICC). Dr. Markley is currently serving a two-year appointed term on the PICC and will continue as liaison. Many of our members hold dual memberships in AACAP and ACLP, and AACAP has generously permitted all SIG members to participate in its professional listserv for several years. With more intentional collaboration, we hope to maximize shared expertise and amplify ACLP’s voice on important issues such as supporting youth boarding in emergency departments or medical units while awaiting psychiatric placement and advancing the management of catatonia in varied clinical settings, particularly given current challenges with access to ECT and the shortage of IV lorazepam.

Looking ahead, we are working to recruit a subcommittee to refresh our SIG webpage and encourage continued use of the Pediatric SIG listserv as a hub for mentorship, clinical dialogue, and cross-institutional collaboration. We are especially excited that our SIG will be featured in the ACLP Case Conference Webinar series this year, with the opportunity to present a pediatric C-L Psychiatry case to colleagues across the field. In addition, we are proud to support Dr. Maryland Pao’s proposal to establish a dedicated Child and Adolescent Psychiatry Award within ACLP, and we will continue to advocate for this important recognition.

We look forward to highlighting the work of our members through these initiatives and to continuing to grow the visibility, impact, and voice of pediatric C-L psychiatry within ACLP.

Visit the Pediatric C-L Psychiatry SIG page on the Academy website here.

PSYCHOLOGICAL CONSIDERATIONS Co-chairs: Craig Lichtman, MD, MBA, FACLP & Janeta Tansey, MD, PhD, FAPA
The SIG brings together C-L psychiatrists interested in promoting the usefulness of a psychological understanding of patients during their care and in integrating psychotherapeutic interventions into clinical practice. The SIG values the full spectrum of psychological perspectives and psychotherapeutic approaches, including but not limited to cognitive, psychodynamic, humanistic, existential, mindfulness-based, and somatic therapies. This year, Dr. Amvrine Ganguly and Dany Lamothe, MD, MA, joined us as vice- chairs, and will step into co-chair positions after this year’s Annual Meeting. Dr. Lamothe specializes in the treatment of somatic symptom disorder, functional somatic syndromes, and, more specifically, disorders of gut–brain interaction in gastroenterology. He has extensive experience with a range of psychotherapeutic modalities, with particular emphasis on short-term psychodynamic therapy and the central role of emotion in patient care. Dr. Ganguly specializes in psycho-oncology, and is trained in Meaning Centered Psychotherapy and on other branches of the third wave psychotherapies and has special interest in phenomenology. If you would like to join in discussions of any topics of interest, discussions of the future of our SIG, or you would like to collaborate on future presentations, please join and visit the Psychological Considerations website for more information. Dr. Lichtman and Dr. Tansey will remain involved in mentoring and leadership roles as past-chairs. We especially thank Dr. Lichtman for his 19 years of service in founding and shepherding the SIG. Please feel free to contact us with questions. Visit the Psychological Considerations SIG page on the Academy website here.

PSYCHOLOGICAL CONSIDERATIONS
Co-chairs: Craig Lichtman, MD, MBA, FACLP & Janeta Tansey, MD, PhD, FAPA

The SIG brings together C-L psychiatrists interested in promoting the usefulness of a psychological understanding of patients during their care and in integrating psychotherapeutic interventions into clinical practice. The SIG values the full spectrum of psychological perspectives and psychotherapeutic approaches, including but not limited to cognitive, psychodynamic, humanistic, existential, mindfulness-based, and somatic therapies.

This year, Dr. Amvrine Ganguly and Dany Lamothe, MD, MA, joined us as vice- chairs, and will step into co-chair positions after this year’s Annual Meeting.

Dr. Lamothe specializes in the treatment of somatic symptom disorder, functional somatic syndromes, and, more specifically, disorders of gut–brain interaction in gastroenterology. He has extensive experience with a range of psychotherapeutic modalities, with particular emphasis on short-term psychodynamic therapy and the central role of emotion in patient care.

Dr. Ganguly specializes in psycho-oncology, and is trained in Meaning Centered Psychotherapy and on other branches of the third wave psychotherapies and has special interest in phenomenology.

If you would like to join in discussions of any topics of interest, discussions of the future of our SIG, or you would like to collaborate on future presentations, please join and visit the Psychological Considerations website for more information.

Dr. Lichtman and Dr. Tansey will remain involved in mentoring and leadership roles as past-chairs. We especially thank Dr. Lichtman for his 19 years of service in founding and shepherding the SIG. Please feel free to contact us with questions.

Visit the Psychological Considerations SIG page on the Academy website here.

Want to join an Academy SIG?

Visit: https://www.clpsychiatry.org/sigs/how-to-join/

You can belong to as many SIGs as you wish, and you do not necessarily need knowledge nor experience of the specialty—if you simply want to learn more, here is your opportunity.

All 2025 ACLP News « October 2025 ACLP News